Drugs / DuoChol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07270796 | Jan → Jul 2027 expected | vaccinia | International Vaccine Institute | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DuoChol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07270796 ↗ |
| Modality | Vaccine | “DuoChol Oral Cholera Vaccine” NCT07270796 ↗ |
| Route | Oral | “2 doses of DuoChol capsule administered orally 14 days apart (Day 0 and Day 14).” NCT07270796 ↗ |